News | Molecular Imaging | June 13, 2017

SNMMI Elects Bennett S. Greenspan, M.D., MS, FACNM, FACR, as President

During 2017 annual meeting new officers elected for 2017-2018

Bennett S. Greenspan, M.D.

Bennett S. Greenspan, M.D.

Bennett S. Greenspan, M.D., MS, FACNM, FACR, professor of radiology at the Medical College of Georgia, Augusta University, in Augusta, Ga., has assumed office as 2017-18 president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2017 Annual Meeting, June 10-14, in Denver, Colorado.      

“As SNMMI President, in the year ahead I will focus on the new Value Initiative and strategic plan, which emphasize quality of practice; research and development; strengthening education and the workforce pipeline; advocacy for molecular imaging, nuclear medicine, and targeted therapy procedures that improve patient care; and outreach that explains the field’s critical role in modern medicine,” Greenspan said.

With the focus on quality and value, Greenspan will continue SNMMI’s development of appropriate use criteria (AUC) and updating procedure guidelines for many nuclear medicine imaging procedures. He will also work on establishing more efficient and timely approval of novel radiotracers. His ultimate focus is on improving patients’ lives. “These improvements can lead to more appropriate utilization of diagnostic nuclear medicine exams and also radionuclide therapy, which will benefit patients,” he explained. “These goals can be facilitated by working closely with other societies and governmental agencies.”

Prior to his position as professor of radiology at the Medical College of Georgia at Augusta University, Greenspan worked at the Mount Sinai School of Medicine in New York, N.Y.; University of Rochester in Rochester, N.Y.; University of Missouri-Columbia; and Washington University in St. Louis, MO.  Greenspan is devoted to teaching clinical nuclear medicine, as well as nuclear medicine physics and radiation safety, to nuclear medicine and radiology residents. He is a member of three committees of the American Association of Physicists in Medicine (AAPM): one on teaching medical physics to radiology residents, one on the development of the medical physics curriculum for radiology residents, and one on the physics of nuclear medicine.

Consistent with his keen interest in ensuring that nuclear medicine delivers the highest quality of care, Greenspan serves on the SNMMI Quality and Evidence Committee, is a reviewer for quality assurance in nuclear medicine for the American College of Radiology (ACR), and was a member of the PET Quality and Reporting Task Force of SNMMI’s PET Center of Excellence. He is a co-author of the paper “Reporting Guidance for Oncologic FDG PET/CT Imaging,” published in the May 2013 issue of The Journal of Nuclear Medicine.

Greenspan holds a Master of Science degree in medical physics from the University of California, Los Angeles, and earned his medical degree at the University of Illinois in Chicago. He served residencies in diagnostic radiology and nuclear medicine and is certified in diagnostic radiology and nuclear radiology by the American Board of Radiology (ABR) and in nuclear medicine by the American Board of Nuclear Medicine (ABNM).

Greenspan’s research and scholarly interests include PET/CT imaging in oncology, especially using PET imaging to further characterize malignancies; evaluation of osteoporosis; and the effects of low-level radiation. He has been a co-investigator on 11 grants.

Greenspan is a Fellow of the ACR and the American College of Nuclear Medicine (ACNM). He currently serves on the boards of the American Board of Science in Nuclear Medicine and the Nuclear Medicine Technology Certification Board. He is past chair of the SNMMI Committee on Councils and served as co-chair of the ACR Nuclear Medicine Procedure Guidelines Committee.

He has been president of the American College of Nuclear Physicians (ACNP), the Missouri Radiological Society, the SNMMI Academic Council (twice), the Missouri Valley Chapter of SNMMI (twice) and the American Board of Science in Nuclear Medicine. At SNMMI, he has served on the Board of Directors and on the boards of the Academic Council, Advanced Associate Council, Nuclear Oncology Council and Computer and Instrumentation Council. Greenspan has also served on the boards of the ACNM, the Intersocietal Commission for the Accreditation of Computed Tomography Laboratories (now the Intersocietal Accreditation Commission – IAC), and the Academy of Radiology Research, as well as on the executive councils of the ACNP and the ACR Intersociety Summer Conference. Greenspan continues to serve on numerous committees and task forces of the SNMMI, ACNM, ACR, Radiological Society of North America, Association of University Radiologists, AAPM and NMTCB. He has also been an ABR oral board examiner. 

Other SNMMI officers elected for 2017-18 are Satoshi Minoshima, M.D., Ph.D., Salt Lake City, Utah, as president-elect, and Vasken Dilsizian, M.D., Baltimore, Maryland, as vice president-elect. SNMMI Technologist Section officers for 2017-18 are Kathleen Krisak, CNMT, FSNMMI-TS, Granby, Mass., as president, and Norman Bolus, MSPH, CNMT, FSNMMI-TS, Birmingham, Alabama, as president-elect.

 

For more information: www.snmmi.org

Related Content

NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...
Bracco Imaging Acquires Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...

Image courtesy of Philips Healthcare

Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale
Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging.
DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
United Imaging Announces First U.S. Clinical Install of uMI 550 Digital PET/CT System
News | PET-CT | June 19, 2019
United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
BGN Technologies Introduces Novel Medical Imaging Radioisotope Production Method
News | Radiopharmaceuticals and Tracers | June 05, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel method for...
Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...